Bacterial survival strategies suggest rethinking cancer cooperativity.

[1]  G. Heppner,et al.  Cancer cell societies and tumor progression , 1993, Stem cells.

[2]  G. V. Vande Woude,et al.  The Met proto-oncogene mesenchymal to epithelial cell conversion. , 1994, Science.

[3]  J. Shapiro,et al.  The significances of bacterial colony patterns , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[4]  Herbert Levine,et al.  Cooperative self-organization of microorganisms , 2000 .

[5]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[6]  K. Kinzler,et al.  Combination bacteriolytic therapy for the treatment of experimental tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Costerton,et al.  Antibiotic resistance of bacteria in biofilms , 2001, The Lancet.

[8]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[9]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[10]  W. Birchmeier,et al.  Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.

[11]  R. Losick,et al.  Cannibalism by Sporulating Bacteria , 2003, Science.

[12]  Valeria Souza,et al.  Stress-Induced Mutagenesis in Bacteria , 2003, Science.

[13]  D. Jarjoura,et al.  Autoschizis of human ovarian carcinoma cells: scanning electron and light microscopy of a new cell death induced by sodium ascorbate: menadione treatment. , 2006, Scanning.

[14]  H. Levine,et al.  Bacterial linguistic communication and social intelligence. , 2004, Trends in microbiology.

[15]  George Oster,et al.  Breaking symmetry in myxobacteria , 2004, Current Biology.

[16]  E. Ben-Jacob,et al.  Self-engineering capabilities of bacteria , 2006, Journal of The Royal Society Interface.

[17]  S. Leibler,et al.  Bacterial Persistence , 2005, Genetics.

[18]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[19]  Jan-Ulrich Kreft,et al.  Dynamics of development and dispersal in sessile microbial communities: examples from Pseudomonas aeruginosa and Pseudomonas putida model biofilms. , 2006, FEMS microbiology letters.

[20]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[21]  C. Maley,et al.  Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .

[22]  K. Pienta,et al.  Evolution of cooperation among tumor cells , 2006, Proceedings of the National Academy of Sciences.

[23]  Gürol M. Süel,et al.  An excitable gene regulatory circuit induces transient cellular differentiation , 2006, Nature.

[24]  M. Pajares,et al.  Alternative splicing: an emerging topic in molecular and clinical oncology. , 2007, The Lancet. Oncology.

[25]  P. Glazer,et al.  Regulation of DNA repair in hypoxic cancer cells , 2007, Cancer and Metastasis Reviews.

[26]  Rajan P Kulkarni,et al.  Tunability and Noise Dependence in Differentiation Dynamics , 2007, Science.

[27]  H. Gerdes,et al.  Tunneling nanotubes: A new route for the exchange of components between animal cells , 2007, FEBS letters.

[28]  H. Vlamakis,et al.  Thinking about Bacillus subtilis as a multicellular organism. , 2007, Current opinion in microbiology.

[29]  Alexander Kamb,et al.  Why is cancer drug discovery so difficult? , 2007, Nature Reviews Drug Discovery.

[30]  S. Rosenberg,et al.  Mutation as a Stress Response and the Regulation of Evolvability , 2007, Critical reviews in biochemistry and molecular biology.

[31]  S. Fais.  Cannibalism: a way to feed on metastatic tumors. , 2007, Cancer letters.

[32]  Helen Y Wang,et al.  Toll-like receptors and immune regulation: implications for cancer therapy , 2008, Oncogene.

[33]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[34]  James J. Collins,et al.  Networking Opportunities for Bacteria , 2008, Cell.

[35]  Robert Axelrod,et al.  Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. , 2008, Translational oncology.

[36]  H. Lage.  An overview of cancer multidrug resistance: a still unsolved problem , 2008, Cellular and Molecular Life Sciences.

[37]  T. Fehm,et al.  Tumor cell dormancy: implications for the biology and treatment of breast cancer   , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[38]  Helen E Blackwell,et al.  Expanding dialogues: from natural autoinducers to non-natural analogues that modulate quorum sensing in Gram-negative bacteria. , 2008, Chemical Society reviews.

[39]  B. Bassler,et al.  Societal interactions in ovarian cancer metastasis: a quorum-sensing hypothesis , 2008, Clinical & Experimental Metastasis.

[40]  J. Dworkin,et al.  A Eukaryotic-like Ser/Thr Kinase Signals Bacteria to Exit Dormancy in Response to Peptidoglycan Fragments , 2008, Cell.

[41]  Larry Norton,et al.  Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.

[42]  Hannah H. Chang,et al.  Non-genetic heterogeneity — a mutation-independent driving force for the somatic evolution of tumours , 2009, Nature Reviews Genetics.

[43]  Graça Raposo,et al.  Exosomes--vesicular carriers for intercellular communication. , 2009, Current opinion in cell biology.

[44]  I. Couzin,et al.  Collective behavior in cancer cell populations , 2009, BioEssays : news and reviews in molecular, cellular and developmental biology.

[45]  Peter G. Wolynes,et al.  Deciding fate in adverse times: Sporulation and competence in Bacillus subtilis , 2009, Proceedings of the National Academy of Sciences.

[46]  B. Bassler,et al.  Bacterial quorum-sensing network architectures. , 2009, Annual review of genetics.

[47]  P. Goss,et al.  Does tumour dormancy offer a therapeutic target? , 2010, Nature Reviews Cancer.

[48]  Jochen Herms,et al.  Real-time imaging reveals the single steps of brain metastasis formation , 2010, Nature Medicine.

[49]  Guo-Cheng Yuan,et al.  Broadly heterogeneous activation of the master regulator for sporulation in Bacillus subtilis , 2010, Proceedings of the National Academy of Sciences.

[50]  Kamlesh Asotra,et al.  Calcium wave signaling in cancer cells. , 2010, Life sciences.

[51]  E. Ben-Jacob,et al.  Lethal protein produced in response to competition between sibling bacterial colonies , 2010, Proceedings of the National Academy of Sciences.

[52]  M. Faretta,et al.  Bacteria-Induced Gap Junctions in Tumors Favor Antigen Cross-Presentation and Antitumor Immunity , 2010, Science Translational Medicine.

[53]  Thomas M. Norman,et al.  An epigenetic switch governing daughter cell separation in Bacillus subtilis. , 2010, Genes & development.

[54]  Federica Cavallo,et al.  2011: the immune hallmarks of cancer , 2011, Cancer Immunology, Immunotherapy.

[55]  A. Chambers,et al.  Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. , 2010, European journal of cancer.

[56]  D. Dubnau.  Swim or chill: lifestyles of a bacillus. , 2010, Genes & development.

[57]  W. Grizzle,et al.  Exosomes and Cancer: A Newly Described Pathway of Immune Suppression , 2011, Clinical Cancer Research.

[58]  C. Lineweaver,et al.  Cancer tumors as Metazoa 1.0: tapping genes of ancient ancestors , 2011, Physical biology.

[59]  Carlo C. Maley,et al.  Solving the Puzzle of Metastasis: The Evolution of Cell Migration in Neoplasms , 2011, PloS one.

[60]  K. Alfarouk,et al.  Tumor Acidity as Evolutionary Spite , 2011, Cancers.

[61]  L. Loeb,et al.  Human cancers express mutator phenotypes: origin, consequences and targeting , 2011, Nature Reviews Cancer.

[62]  Jonathan W. Uhr,et al.  Controversies in clinical cancer dormancy , 2011, Proceedings of the National Academy of Sciences.

[63]  Robert H. Austin,et al.  An analogy between the evolution of drug resistance in bacterial communities and malignant tissues , 2011, Nature Reviews Cancer.

[64]  W. Cavenee,et al.  Heterogeneity maintenance in glioblastoma: a social network. , 2011, Cancer research.

[65]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[66]  Tom Misteli,et al.  RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E) , 2011, Nature.

[67]  C. Bansal,et al.  Cell Cannibalism: A cytological study in effusion samples , 2011, Journal of cytology.

[68]  Gürol M. Süel,et al.  Temporal competition between differentiation programs determines cell fate choice , 2011, Molecular systems biology.

[69]  E. Ben-Jacob,et al.  “Self-Assisted” Amoeboid Navigation in Complex Environments , 2011, PloS one.

[70]  Steven J. Greco,et al.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. , 2011, Cancer research.

[71]  Clinton C. Dawson,et al.  “Persisters”: Survival at the Cellular Level , 2011, PLoS pathogens.

[72]  S. Elankumaran,et al.  Mathematical model of the role of intercellular signalling in intercellular cooperation during tumorigenesis , 2011, Cell proliferation.

[73]  Ciro Tetta,et al.  Exosome/microvesicle-mediated epigenetic reprogramming of cells. , 2011, American journal of cancer research.

[74]  Denis Wirtz,et al.  The physics of cancer: the role of physical interactions and mechanical forces in metastasis , 2011, Nature Reviews Cancer.

[75]  Chih-kuan Tung,et al.  Acceleration of Emergence of Bacterial Antibiotic Resistance in Connected Microenvironments , 2011, Science.

[76]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[77]  L. Vannucci,et al.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases , 2011, Cellular and Molecular Immunology.

[78]  M. Glickman,et al.  Converting Cancer Therapies into Cures: Lessons from Infectious Diseases , 2012, Cell.